A “new” role of amantadines in COVID-19 in patients with Parkinson’s disease: results of own comparative study

A “new” role of amantadines in COVID-19 in patients with Parkinson’s disease: results of own comparative study

Amantadine has begun to be used as a possible alternative in COVID-19 therapy to mitigate its effects. There is anecdotal evidence that patients with Parkinson's disease (PD) treated with amantadine and who test positive for COVID-19 often do not develop clinical manifestations of COVID-19.Obje...

Full description

Bibliographic Details
Main Authors: Z. A. Zalyalova, S. E. Munasipova, D. M. Khasanova, G. R. Ilyina, Z. G. Khayatova, N. I. Bagdanova
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2022-12-01
Series:Неврология, нейропсихиатрия, психосоматика
Subjects:
parkinson's disease
covid-19
new coronavirus infection
amantadine sulfate
levodopa
α-synuclein
pneumonia
Online Access:https://nnp.ima-press.net/nnp/article/view/1919

Similar Items

Similar Items